Icke-inlagda patienter” - nomesco

THE HEALTH OF ELDERLY PEOPLE
Table 13 Consumption of medication for chronic obstructive pulmonary disease,
DDD/1000 inhabitants/day 2006
Denmark Finland Åland Iceland Norway Sweden
Adrenergic inhalants
(R03A)
Men
0-64 23.2 17.3 18.5 17.8 25.7 17.7
65-69 74.0 50.8 67.3 64.7 77.8 45.7
70-74 109.1 65.7 100.7 80.1 97.4 55.4
75-79 128.2 79.2 81.1 83.3 96.0 65.1
80-84 115.0 87.3 94.2 71.8 103.4 64.0
85+
Women
71.9 66.7 63.8 44.7 73.6 59.2
0-64 26.8 22.4 22.3 24.5 31.5 23.3
65-69 92.9 56.4 66.2 90.7 90.6 64.7
70-74 117.2 61.9 81.6 100.7 95.1 66.7
75-79 110.9 63.7 74.4 92.7 91.1 64.1
80-84 77.1 55.6 89.9 64.0 70.0 55.3
85+
Consumption of other
drugs for chronic obstructive
pulmonary disease
(R03B)
Men
41.4 39.4 30.2 45.4 44.0 42.6
0-64 11.8 9.1 9.2 4.8 9.4 9.5
65-69 39.7 31.0 21.2 21.1 50.0 37.9
70-74 56.6 41.6 55.5 34.2 71.0 49.9
75-79 69.0 49.8 32.2 38.1 76.7 60.5
80-84 63.6 53.4 46.7 39.2 90.3 64.4
85+
Women
41.0 44.9 58.1 28.0 69.8 64.6
0-64 14.8 13.1 8.6 6.6 11.5 14.0
65-69 53.7 36.7 24.4 40.7 52.2 54.9
70-74 66.3 39.5 35.1 43.6 63.6 61.3
75-79 64.3 40.0 46.9 38.4 66.6 59.2
80-84 47.2 36.2 43.1 25.5 56.8 53.6
85+ 25.5 24.9 10.9 18.5 36.8 41.0
Sources D: Danish Medicines Agency; Fl: Chief Pharmaceutical Officer; G: Medical Officer;
F & Å: National Agency for Medicines; I: Icelandic Medicines Control Agency; N:
WHO Collaborating Centre for Drug Statistics Methodology; S: National Corporation
Pneumonia and the use of
antibiotics
The widespread use of antibiotics has
been strongly criticised because of the increased
risk of the development of resistance.
In all countries, it is recommended
320
Lunginflammation och
antibiotikaanvändning
Den omfattande användningen av antibiotika
har kritiserats starkt på grund av
den ökande risken för resistensutveckling.
I alla länder rekommenderar man